Angelman syndrome: Mimicking conditions and phenotypes

American Journal of Medical Genetics

Volumn 101, Issue 1, 2001, Pages 59-64

  Williams, Charles A ^a   Lossie, Amy ^a   Driscoll, Daniel ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Angelman syndrome; Diagnosis; Mimicking conditions; Phenotype

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ALPHA THALASSEMIA; ARTICLE; AUTISM; BONE DYSPLASIA; BRAIN DISEASE; CEREBRAL PALSY; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 22; CHROMOSOME 4; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENZYME DEFICIENCY; GENE DELETION; GENE DUPLICATION; GROWTH RETARDATION; GURRIERI SYNDROME; HAPPY PUPPET SYNDROME; HUMAN; LENNOX GASTAUT SYNDROME; MOLECULAR MIMICRY; PRIORITY JOURNAL; RETT SYNDROME;

ANGELMAN SYNDROME; CHILD; DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; HUMANS; METABOLISM, INBORN ERRORS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PHENOTYPE; RETT SYNDROME;

EID: 0035371487     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.1316     Document Type: Article

References (32)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 [see comments]. Nat Genet 23:185-188.
2. Angelman H. 1965. "Puppet" children: a report on three cases. Dev Med Child Neurol 7:681-688.
3. Arn PH, Williams CA, Zori RT, Driscoll DJ, Rosenblatt DS. 1998. Methylenetetrahydrofolate reductase deficiency in a patient with phenotypic findings of Angelman syndrome. Am J Med Genet 77:198-200.
4. Bass N. 1999. Cerebral palsy and neurodegenerative disease. Curr Opin Pediatr 11:504-507.
5. Battaglia A, Gurrieri F. 1999. Case of apparent Gurrieri syndrome showing molecular findings of Angelman syndrome [letter; comment]. Am J Med Genet 82:100.
6. Boyd SG, Harden A, Patton MA. 1988. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr 147:508-513.
7. Clarke A. 1996. Rett syndrome. J Med Genet 33:693-699.
8. Clayton-Smith J, Pembrey ME. 1992. Angelman syndrome. J Med Genet 29:412-415.
9. Dupont JM, Le Tessier D, Rabineau D, Cuisset L, Vasseur C, Jeanpierre M, Delpech M, Pinton F, Ponsot G, Denavit MF. 1999. Unexpected Angelman syndrome molecular defect in a girl displaying clinical features of Prader-Willi syndrome [letter]. J Med Genet 36:652-654.
10. Ellaway C, Buchholz T, Smith A, Leonard H, Christodoulou J. 1998. Rett syndrome: significant clinical overlap with Angelman syndrome but not with methylation status. J Child Neurol 13:448-451.
11. Gibbons RJ, Brueton L, Buckle VJ, Burn J, Clayton-Smith J, Davison BC, Gardner RJ, Homfray T, Kearney L, Kingston HM, et al. 1995. Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet 55:288-299.
12. Guerrini R, Shanahan JL, Carrozzo R, Bonanni P, Higgs DR, Gibbons RJ. 2000. A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy. Ann Neurol 47:117-121.
13. Innes AM, Chudley AE, Carson NL, Dawson AJ. 1999. Interstitial 4p deletion in a child with an Angelman syndrome-like phenotype [letter]. Clin Genet 56:238-241.
14. Jiang Y, Lev-Lehman E, Bressler J, Tsai TF, Beaudet AL. 1999. Genetics of Angelman syndrome. Am J Hum Genet 65:1-6.
15. Mann MR, Bartolomei MS 1999. Towards a molecular understanding of Prader-Willi and Angelman Syndromes. Hum Mol Genet 8:1867-1873.
16. Markand ON. 1977. Slow spike-wave activity in EEG and associated clinical features: often called "Lennox" or "Lennox-Gastaut" syndrome. Neurology 27:746-757.
17. Mickelson EC, Robinson WP, Hrynchak MA, Lewis ME. 1997. Novel case of del(17)(q23.1q23.3) further highlights a recognizable phenotype involving deletions of chromosome (17)(q21q24). Am J Med Genet 71:275-279.
18. Mowat DR, Croaker GD, Cass DT, Kerr BA, Chaitow J, Ades LC, Chia NL, Wilson MJ. 1998. Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23. J Med Genet 35:617-623.
19. Nissenkorn A, Zeharia A, Lev D, Watemberg N, Fattal-Valevski A, Barash V, Gutman A, Harel S, Lerman-Sagie T. 2000. Neurologic presentations of mitochondrial disorders. J Child Neurol 15:44-48.
20. Praphanphoj V, Goodman BK, Thomas GH, Raymond GV. 2000. Cryptic subtelomeric translocations in the 22q13 deletion syndrome. J Med Genet 37:58-61.
21. Precht KS, Lese CM, Spiro RP, Huttenlocher PR, Johnston KM, Baker JC, Christian SL, Kittikamron K, Ledbetter DH. 1998. Two 22q telomere deletions serendipitously detected by FISH. J Med Genet 35:939-942.
22. Rantala H, Putkonen T, 1999. Occurrence, outcome, and prognostic factors of infantile spasms and Lennox-Gastaut syndrome. Epilepsia 40:286-289.
23. Repetto GM, White LM, Bader PJ, Johnson D, Knoll JH. 1998. Interstitial duplications of chromosome region 15q11q13: clinical and molecular characterization. Am J Med Genet 79:82-89.
24. Schinzel A, Braegger CP, Brecevic L, Dutly F, Binkert F. 1997. Interstitial deletion, del(4)(q12q21.1), owing to de novo unbalanced translocation in a 2 year old girl: further evidence that the piebald trait maps to proximal 4q12. J Med Genet 34:692-695.
25. Schroer RJ, Phelan MC, Michaelis RC, Crawford EC, Skinner SA, Cuccaro M, Simensen RJ, Bishop J, Skinner C, Fender D, Stevenson RE. 1998. Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 76:327-336.
26. Slavotinek A, Kingston H. 1997. Interstitial deletion of bands 4q12→q13.1: case report and review of proximal 4q deletions. J Med Genet 34:862-865.
27. Steffenburg S, Gillberg CL, Steffenburg U, Kyllerman M. 1996. Autism in Angelman syndrome: a population-based study. Pediatr Neurol 14:131-136.
28. Villard L, Bonino MC, Abidi F, Ragusa A, Belougne J, Lossi AM, Seaver L, Bonnefont JP, Romano C, Fichera M, Lacombe D, Hanauer A, Philip N, Schwartz C, Fontes M. 1999. Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome. J Med Genet 36:183-186.
29. Volkmar F, Cook EH, Jr, Pomeroy J, Realmuto G, Tanguay P. 1999. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 38:32S-54S.
30. Williams CA, Angelman H, Clayton-Smith J, Driscoll DJ, Hendrickson JE, Knoll JH, Magenis RE, Schinzel A, Wagstaff J, Whidden EM, et al. 1995. Angelman syndrome: consensus for diagnostic criteria, Angelman Syndrome Foundation. Am J Med Genet 56:237-238.
31. Wong AC, Ning Y, Flint J, Clark K, Dumanski JP, Ledbetter DH, McDermid HE. 1997. Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. Am J Hum Genet 60:113-120.
32. Xiang F, Buervenich S, Nicolao P, Bailey ME, Zhang Z, Anvret M. 2000. Mutation screening in Rett syndrome patients. J Med Genet 37:250-255.